Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digitoxin for Androgen-Independent Prostate Cancer (pilot phase II)
2006-005493-52Phase 2Terminated
- Sponsor
- Skaraborgs Sjukhus Skövde
- Start
- Nov 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of digitoxin in prostate cancer (PCa), sponsored by Skaraborgs Sjukhus Skövde. Primary endpoint: PSA response rate. Started Nov 2006; status: terminated.
02
Drugs
digitoxin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2006-005493-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005493-52.